Comprehensive study on control of chronic antibody-mediated rejection after renal transplantation
Project/Area Number |
25293335
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Aichi Medical University (2015) Nagoya University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
IWASAKI Kenta 愛知医科大学, 医学部, 准教授 (10508881)
MIWA Yuko 愛知医科大学, 医学部, その他 (90572941)
MARUYAMA Shoichi 名古屋大学, 大学院医学系研究科, 准教授 (10362253)
ONISHI Akira 日本大学, 生物資源科学部, 教授 (30414890)
OGAWA Haruko 帯広畜産大学, 学内共同利用施設等, 教授 (10400079)
HANEDA Masataka 名古屋大学, 大学院医学系研究科, 寄附講座講師 (50436995)
|
Research Collaborator |
KUZUYA Takafumi
MATSUDA Yoshiko
YAMAMOTO Takayuki
HIRAMITSU Takahisa
Ashimine Satoshi
INANAGA Yukiko
HORIMI Kosei
KITAHATA Nana
LIU DaGe
KUSHIHARA Hideyuki
KURATA Yoko
OKADA Manabu
MATSUOKA Yutaka
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥17,940,000 (Direct Cost: ¥13,800,000、Indirect Cost: ¥4,140,000)
Fiscal Year 2015: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2013: ¥7,540,000 (Direct Cost: ¥5,800,000、Indirect Cost: ¥1,740,000)
|
Keywords | 移植・再生医療 / 腎移植 / 慢性抗体関連型拒絶反応 / 免疫学 / マイクロアレイ / シグナル伝達 / クローンブタ |
Outline of Final Research Achievements |
Donor specific HLA antibody (DSA)-induced chronic antibody-mediated rejection (CAMR) is an obstacle to long-term graft survival. Approximately 40% of renal transplant recipient with de novo DSA without graft dysfunction demonstrated biopsy-proven subclinical CAMR, and failed to respond to anti-rejection therapy such as anti-CD20 monoclonal antibody and double filtration plasmapheresis. miR-142-5p and miR-486-5p in peripheral blood mononuclear cells were associated with DSA production and CAMR, respectively. DSA with high complement binding ability showed high risk of CAMR. Anti-A/B antibody, mTOR inhibitor and AMPK activator had protective function against HLA antibody-induced, complement-dependent cytotoxicity. Action at an early stage when immune response starts to move towards DSA production would be essential to control CAMR after kidney transplantation. Furthermore, development of innovative anti-CAMR therapy is necessary.
|
Report
(4 results)
Research Products
(62 results)
-
[Journal Article] De novo anti-HLA DSA characteristics and subclinical antibody-mediated kidney allograft injury.2016
Author(s)
Yamamoto T, Watarai Y, Takeda A, Tsujita M, Hiramitsu T, Goto N, Narumi S, Katayama A, Morozumi K, Uchida K, Kobayashi T.
-
Journal Title
Transplantation
Volume: 未定
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
[Journal Article] MiR-142-5p, miR-182, and miR-486-5p as a biomarker for early detection of chronic antibody-mediated rejection in kidney transplantation.2016
Author(s)
Iwasaki K, Yamamoto T, Inanaga Y, Hiramitsu T, Miwa Y, Haneda M, Narumi S, Watarai Y, Katayama A, Uchida K, Kobayashi T.
-
Journal Title
Biomarker Insights
Volume: 未定
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
[Journal Article] Encephalitis Due to Human Herpesvirus-6B in Pancreas After Kidney (PAK) Transplantation2014
Author(s)
Yamamoto T, Watarai Y, Goto N, Horikoshi Y, Yamada S, Yasui K, Tsujita M, Hiramitsu T, Narumi S, Katayama A, Uchida K, Kobayashi T.
-
Journal Title
Transplant Infectious Disease
Volume: 16
Issue: 5
Pages: 853-858
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Acute antibody-mediated rejection possibly due to anti-hman leukocyte antigen DQB1 antibodies after renal transplantation - case report2014
Author(s)
S. Yamanaga, Y. Watarai, A. Takeda, T. Yamamoto, T. Hiramitsu, M. Tsujita, N. Goto, K. Uchida, A. Katayama, K. Morozumi, T. Kobayashi
-
Journal Title
Transplantation Proceedings
Volume: 46
Issue: 2
Pages: 640-643
DOI
Related Report
Peer Reviewed
-
[Journal Article] Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches2013
Author(s)
Shigeyoshi Yamanaga,Yoshihiko Watarai,Takayuki Yamamoto,Makoto Tsujita,Takahisa Hiramitsu,Koji Nanmoku,Norihiko Goto,Asami Takeda,Kunio Morozumi,Akio Katayama,Hiroh Saji,Kazuharu Uchida,and Takaaki Kobayashi
-
Journal Title
Human Immunology
Volume: 74巻
Issue: 9
Pages: 1111-1118
DOI
Related Report
Peer Reviewed
-
-
-
[Presentation] 異種移植と免疫順応2015
Author(s)
岩﨑研太、三輪祐子、大西彰、小林孝彰
Organizer
第42回 日本臓器保存生物医学会
Place of Presentation
いわて県民情報交流センター(岩手県盛岡市)
Year and Date
2015-11-13
Related Report
-
-
-
-
-
-
[Presentation] Rituximab sparing protocol for patients with low titers in ABO incompatible kidney transplantation2015
Author(s)
S. Narumi, Y. Watarai, N. Goto, T. Hiramitsu, M, Tsujita, T. Yamamoto, M. Okada, K. Itoh, K. Futamura, T. Kobayashi
Organizer
17th Congress of the European Society for Organ Transplantation
Place of Presentation
Brussels (Belgium)
Year and Date
2015-09-13
Related Report
Int'l Joint Research
-
[Presentation] Safety and efficacy of low dose and very low dose extended -release tacrolimus/MMF in de novo kidney transplant recipients2015
Author(s)
S. Narumi, Y. Watarai, N. Goto, T. Hiramitsu, M, Tsujita, T. Yamamoto, M. Okada, K. Itoh, K. Futamura, T. Kobayashi
Organizer
17th Congress of the European Society for Organ Transplantation
Place of Presentation
Brussels (Belgium)
Year and Date
2015-09-13
Related Report
Int'l Joint Research
-
-
-
[Presentation] Favorable Results of ABO Incompatible Renal Transplantation Without B Cell Targeted Therapy: Advantages and Disadvantages of Rituximab Pretreatment2015
Author(s)
M. Okada, K. Futamura, K. Itou, T. Yamamoto, T. Hiramitsu, M. Tsujita, N. Goto, S. Narumi, Y. Watarai, A. Katayama, K. Uchida, T. Kobayashi.
Organizer
ATC (American Transplant Congress) 2015
Place of Presentation
Philadelphia (USA)
Year and Date
2015-05-02
Related Report
Int'l Joint Research
-
[Presentation] Clinical Significance of Estimated DSA MFI Values at 1,000 C1q MFI for Differentiation Between Harmful and Harmless DSA2015
Author(s)
K. Horimi, T. Akaza, K. Kuroki, S. Sakamoto, Y. Matsuoka, Y. Watarai, S. Narumi, A. Katayama, K. Uchida, T. Kobayashi.
Organizer
ATC (American Transplant Congress) 2015
Place of Presentation
Philadelphia (USA)
Year and Date
2015-05-02
Related Report
Int'l Joint Research
-
-
-
-
-
[Presentation] 異種移植の現状と課題2015
Author(s)
小林孝彰
Organizer
平成26年度獣医学術学会年次大会
Place of Presentation
岡山コンベンションセンター(岡山県岡山市)
Year and Date
2015-02-13 – 2015-02-15
Related Report
Invited
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Changes in Non-Donor-Specific Antibodies After Human Leukocyte Antigen-Incompatible Renal Transplantation Would Also Be Worthy of Attention.2014
Author(s)
S. Yamanaga, M. Toyoda, Y. Hidaka, Y. Watarai, A. Takeda, K. Morozumi, A. Katayama, K. Uchida, S. Uekihara, I. Seishi, T. Kobayashi.
Organizer
WTC 2014 (World Transplant Congress)
Place of Presentation
San Francisco (USA)
Year and Date
2014-07-26 – 2014-07-31
Related Report
-
-
[Presentation] HLA Specificity and Titer Rather Than Complement Fixing Ability of DSA Would Influence the Incidence of Chronic Antibody Mediated Rejection.2014
Author(s)
T. Yamamoto, Y. Watarai, K. Kuroki, S. Sakamoto, M. Hiramatsu, M. Tsujita, T. Hiramitsu, N. Goto, S. Narumi, K. Uchida, T. Kobayashi.
Organizer
WTC 2014 (World Transplant Congress)
Place of Presentation
San Francisco (USA)
Year and Date
2014-07-26 – 2014-07-31
Related Report
-
-
-
-
[Presentation] Analysis of donor ABO antigen expression in ABO incompatible kidney transplantation2013
Author(s)
Yuko Miwa, Takayuki Yamamoto, Yoshimi Shintoku, Kenta Iwasaki, Masataka Haneda,Norihiko Goto, Yoshihiko Watarai, Asami Takeda, Kunio Morozumi, Yuriko Sawa, Shoichi Maruyama,Kazuharu Uchida, Takaaki Kobayashi
Organizer
Congress of Asian Society of Transplantation (CAST) 2013
Place of Presentation
Kyoto International Conference Center (Kyoto, Japan)
Related Report
-
[Presentation] Reduced expression of complement regulatory protein, CD59, by anti-HLA class II DR antibody binding to endothelial cells: Implication for blockade in graft accommodation2013
Author(s)
Kenta Iwasaki, Jing Ping, Miwa Yuko, Haneda Masataka, Kuzuya Takafumi, Ogawa Haruko, Onishi Akira, Kobayashi Takaaki
Organizer
Congress of Asian Society of Transplantation (CAST) 2013
Place of Presentation
Kyoto International Conference Center (Kyoto, Japan)
Related Report
-
-
-
[Presentation] Porcine adipose-derived MSC might have a risk of enhancing T cell response, unlike human, mouse or rat MSC2013
Author(s)
Yukiko Inanaga, Kenta Iwasaki, Yuko Miwa, Masataka Haneda, Akira Onishi, Shoichi Maruyama, Asako Ando, Takaaki Kobayashi
Organizer
International Xenotransplantation Association (IXA) 2013
Place of Presentation
Osaka International Convention Center (Osaka, Japan)
Related Report
-
-
-
-
-